Resultados de la búsqueda
Medina-Hernández D, Galán-Arriola C, Sánchez-González J, Ochala J, Ibáñez B. Anthracycline cardiotoxicity is associated with aberrant cardiac myosin energetics. Rev Esp Cardiol (2025) S1885-5857:00054-4
Rubini Giménez M, Koechlin L, López-Ayala P, Spagnuolo C, Boeddinghaus J, Wildi K, Nestelberger T, Tkachenko H, Basic D, Kaplan E, Formambuh J, Bima P, Glaeser J, Crisanti L, Miró Ó, Martín-Sánchez FJ, Christ M, Keller DI, Gualandro DM, Kawecki D, Rentsch K, Buser A, Strebel I, Mahfoud F, Mueller C; APACE Investigators; Hure G, Rumora K, Muench-Gerber T, Glarner N, Puelacher C, Twerenbold R, Wussler D, du Fay de Lavallaz J, Zimmermann T, Reinhardt J, Morawiec B, Munzk P, Geigy N, Shrestha S, Martinez-Nadal G, Fuenzalida C, Calderón S, Rodriguez Adrada E, Ganovská E, Parenica J, von Eckardstein A. Clinical implications of sex-specific upper reference limits for high-sensitivity cardiac troponin I in myocardial infarction diagnosis. Rev Esp Cardiol (2025) S1885-5857:00147-1
Sanz-Sánchez J, Santos Martínez S, Rumiz González E, Oteo Domínguez JF, Tejada Ponce D, Gómez Menchero A, Sánchez Elvira G, Fuertes Ferre G, Rivero Crespo F, Lukic Otanovic A, Díaz Fernández J, Galindo Fernández E, Urbano Carrillo C, Salvatella Giralt N, Torres Sánchez M, García Touchard A, Ibáñez Cabeza B, Stefanini G, Alfonso Manterola F, García García H, Amat-Santos IJ. Reduced stent strategy versus conventional percutaneous coronary revascularization in patients presenting with STEMI: the COPERNICAN trial. Rev Esp Cardiol (2025) S1885-5857:00150-1
Rossello X, Gonzalez-Manzanares R, Amat-Santos I, Peral Disdier V, Nieto Roca L, López Otero D, Nombela Franco L, Gheorge L, Sanz-Sánchez J, Gómez Herrero J, González Ferreiro R, Muñoz García AJ, Vilalta V, Ojeda S, Veiga Fernández G, Córdoba Soriano JG, Regueiro A, Sandín Rollán M, Flores Ríos X, Uribarri A, Martín Reyes R, Romaguera R, Avanzas P, García Blas S, Franco-Peláez JA, Martín Moreiras J, Ramón González Juanatey J, Tirado G, Calle G, Díez JL, Santos-Martínez S, Melendo Viu M, Carrillo Suarez X, Sanmartín X, Gonzalo N, Gutiérrez Barrios A, González Bermúdez I, Real C, Fuster V, Ibáñez B, Raposeiras-Roubín S. Use of the win ratio approach to assess outcomes in the DapaTAVI trial Rev Esp Cardiol (2025) S1885-5857:00241-5
Gómez-Talavera S, Navarro-Guzmán Á, Fernández-Jiménez R, Fuster V, Sánchez-González J, Ibáñez B. ESSOS single breath-hold 3D magnetic resonance for the assessment of aortic dilation. Rev Esp Cardiol (2025) S1885-5857:00192-6
Salinas P, Romaguera R, Gómez-Lara J, Brugaletta S, Gómez-Menchero A, Martín P, Romero M, García-Blas S, Jiménez M, Jiménez VA, Bordes P, Bayón J, Salvatella N, Alameda M, Hyun-Lee D, Trillo-Nouche R, López-Benito M, Frutos A, Moreu J, García Del Blanco B, Mohandes M, Bosa Ojeda F, Hernández Hernández F, Pinar-Bermúdez E, Jiménez-Quevedo P, Rosselló X, Pocock S, Sabaté M, Gómez-Hospital JA, Comin-Colet J, Gonzalo N, Fernández Ortiz A; SUGAR trial Investigators. Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: extended follow-up of the SUGAR randomised controlled trial. Heart (2025) Jun 25 [Epub ahead of print]
Nogales P; Velasco C; González-Cintado L; Sharysh D; Mota-Cobián A; Torroja C; Morales-Cano D; Mota R; Benguría A; Izquierdo-Serrano R; Dopazo A; Sánchez-Cabo F; España S; Carramolino L; Mateo J; Bentzon J. 18FDG-pet imaging reveals glycolytic activity as a marker of atherosclerotic disease activity Atherosclerosis (2025) 407
Rossello X, Gonzalez-Del-Hoyo M, Aktaa S, Gale CP, Barbash I, Claeys MJ, Coughlan JJ, Ferreira JP, Galbraith M, Leosdottir M, Schiele F, Raposeiras-Roubin S, Gimenez MR, Byrne RA, Ibanez B. European Society of Cardiology quality indicators for the management of acute coronary syndromes: developed in collaboration with the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the ESC. Eur Heart J Acute Cardiovasc Care (2025) 14:145-154
